Epilepsy Treatment: A Doctor’s Complete Guide
By Dr. Sagar Rajkuwar, MS-ENT, Nashik, Maharashtra, India. Clinic Website: www.entspecialistinnashik.com
Table of Contents
- Introduction & Quick Answer
- Goals of Epilepsy Treatment
- When to Start Epilepsy Treatment
- Anti-Seizure Medications (ASMs)
- Status Epilepticus Emergency Treatment
- Drug-Resistant Epilepsy
- Surgical Epilepsy Treatment
- Neuromodulation
- Ketogenic & Modified Atkins Diets
- Cannabidiol & New Agents
- Epilepsy Treatment in Women & Pregnancy
- Pediatric Epilepsy Treatment
- Elderly Epilepsy Treatment
- Lifestyle, Trigger Avoidance & Safety
- Monitoring & Follow-up
- Infographic: Epilepsy Treatment Pathway
- The Indian Context
- Latest 2024–2026 Evidence
- Myths vs Facts
- 10 Frequently Asked Questions
- Summary
- Conclusion
- References
Introduction & Quick Answer
Quick Answer: Epilepsy treatment aims for seizure freedom with minimal side effects. First-line therapy is an anti-seizure medication (ASM) chosen by seizure type: levetiracetam, lamotrigine, or lacosamide for focal seizures; valproate, levetiracetam, or lamotrigine for generalised tonic-clonic seizures; ethosuximide for absence seizures; valproate for juvenile myoclonic epilepsy (avoid in women of child-bearing age). Status epilepticus is a medical emergency treated with IV benzodiazepines (lorazepam, midazolam) then levetiracetam, fosphenytoin, or valproate. Around 70% of patients become seizure-free with the first or second drug. For the remaining 30%, options include epilepsy surgery, vagus nerve stimulation (VNS), responsive neurostimulation (RNS), deep brain stimulation (DBS), ketogenic diet, and newer agents like cannabidiol (CBD), cenobamate, and fenfluramine.
Patients and families ask me every week what the best epilepsy treatment is. The honest answer: the best treatment is the one that stops seizures in that patient with the fewest side effects. This guide draws on WHO, International League Against Epilepsy (ILAE), NICE, NHS, American Academy of Neurology (AAN), American Epilepsy Society, and Indian Epilepsy Society 2024–2026 guidance.
Goals of Epilepsy Treatment
- Complete seizure freedom (ideal)
- No or minimal side effects
- Normal cognitive and emotional function
- Return to full daily life (school, work, driving where allowed)
- Prevention of sudden unexpected death in epilepsy (SUDEP)
- Protection of bone, mood, and reproductive health
When to Start Epilepsy Treatment
Start ASM after:
- Two unprovoked seizures (classical ILAE criterion); OR
- One unprovoked seizure with high recurrence risk (abnormal EEG, structural lesion on MRI, nocturnal seizure, prior brain injury); OR
- Diagnosis of an epilepsy syndrome
Monotherapy is tried first — about 70% of patients respond. If the first ASM fails, switch to another monotherapy before combining drugs.
Anti-Seizure Medications (ASMs)
For Focal Seizures (Partial-Onset)
- Levetiracetam (Keppra) — favourable profile, weight-neutral, minimal interactions
- Lamotrigine (Lamictal) — well tolerated, mood-stabilising, slow titration to avoid rash
- Lacosamide (Vimpat) — add-on or monotherapy
- Oxcarbazepine, eslicarbazepine
- Carbamazepine — effective but many interactions and HLA-B*1502 risk in Asians (Stevens-Johnson syndrome)
- Perampanel, brivaracetam, cenobamate (newer)
For Generalised Tonic-Clonic Seizures
- Valproate — most effective; avoid in women of child-bearing potential (teratogenic)
- Levetiracetam
- Lamotrigine
- Topiramate, zonisamide
For Absence Seizures
- Ethosuximide — first line in childhood absence epilepsy
- Valproate — if generalised tonic-clonic coexist
- Lamotrigine — alternative
For Myoclonic Seizures / Juvenile Myoclonic Epilepsy
- Valproate — most effective (avoid in women of child-bearing potential)
- Levetiracetam
- Topiramate, zonisamide
Status Epilepticus Emergency Treatment
Any seizure lasting > 5 minutes or two seizures without recovery between is status epilepticus, a medical emergency with 15–20% mortality.
- Stage 1 (0–5 min): ABC, oxygen, IV access, check glucose. If undiagnosed give thiamine and glucose.
- Stage 2 (5–20 min): IV lorazepam 0.1 mg/kg (max 4 mg), or IM/buccal midazolam 10 mg if no IV.
- Stage 3 (20–40 min): IV levetiracetam 60 mg/kg, fosphenytoin 20 mg PE/kg, or valproate 40 mg/kg (ESETT trial — all three equally effective).
- Stage 4 (> 40 min — refractory): ICU admission, propofol, midazolam, or thiopentone infusion with EEG monitoring and intubation.
Drug-Resistant Epilepsy
Defined as persistent seizures after adequate trials of two tolerated, appropriately chosen ASMs. Affects 30% of all epilepsy patients. Needs referral to a comprehensive epilepsy centre for:
- Pre-surgical evaluation (video-EEG, MRI, PET, SPECT)
- Consideration of resective surgery
- Neuromodulation (VNS, RNS, DBS)
- Dietary therapy (ketogenic diet)
- Clinical trial of newer ASM
Surgical Epilepsy Treatment
- Anterior temporal lobectomy — most effective; 60–80% seizure freedom in mesial temporal sclerosis
- Lesionectomy for focal cortical dysplasia, tumour, cavernoma
- Hemispherectomy / functional hemispherotomy for severe childhood hemispheric epilepsies
- Corpus callosotomy for drop attacks
- Laser interstitial thermal therapy (LITT) — minimally invasive
- Stereo-EEG-guided radiofrequency thermocoagulation
Neuromodulation
- Vagus nerve stimulation (VNS) — reduces seizures by 50% in ~50% of patients
- Responsive neurostimulation (RNS) — closed-loop cortical stimulation
- Deep brain stimulation (DBS) of anterior thalamus — SANTE trial-proven
- External trigeminal nerve stimulation (eTNS)
Ketogenic & Modified Atkins Diets
The ketogenic diet (high fat, very low carbohydrate, moderate protein) was developed in the 1920s and remains effective, especially in children with drug-resistant epilepsy (Lennox-Gastaut, Dravet, infantile spasms). The modified Atkins diet is better tolerated by adults.
- Monitor lipids, growth, bone health, kidney stones
- Dietitian supervision essential
- Supplementation with multivitamins, calcium, vitamin D, carnitine
Cannabidiol & New Agents
- Cannabidiol (Epidiolex) — approved for Dravet, Lennox-Gastaut, tuberous sclerosis complex
- Fenfluramine — Dravet syndrome
- Cenobamate — focal seizures with impressive seizure-freedom rates
- Everolimus — tuberous sclerosis complex
- Ganaxolone — CDKL5 deficiency, status epilepticus
Epilepsy Treatment in Women & Pregnancy
- Avoid valproate in women of child-bearing potential (10% major malformation rate, autism and cognitive risks)
- Preferred in pregnancy: lamotrigine, levetiracetam
- Pre-conception folic acid 5 mg/day
- Monitor drug levels (lamotrigine clearance rises in pregnancy)
- Vitamin K 10 mg/day in last month if on enzyme-inducing ASM
- Breastfeeding generally safe with most ASMs
- Contraception: enzyme-inducers reduce OCP efficacy
- Pregnancy registries: EURAP, NAAED
Pediatric Epilepsy Treatment
- Infantile spasms: vigabatrin, ACTH, oral prednisolone
- Dravet syndrome: valproate + clobazam + stiripentol or fenfluramine
- Lennox-Gastaut: valproate, lamotrigine, rufinamide, CBD, ketogenic diet
- Benign rolandic epilepsy: often no treatment needed
- Avoid carbamazepine, oxcarbazepine in generalised epilepsies
- Monitor cognitive and behavioural development
Elderly Epilepsy Treatment
- Start low, go slow
- Prefer levetiracetam, lamotrigine, lacosamide
- Beware of hyponatraemia with oxcarbazepine
- Falls risk from phenytoin, carbamazepine
- Interaction with warfarin, DOACs, statins
- Bone health — DEXA, vitamin D
Lifestyle, Trigger Avoidance & Safety
- Regular sleep (7–8 h)
- Limit alcohol
- Avoid flashing lights if photosensitive
- Manage stress
- Shower (not bath), supervised swimming
- Driving: country-specific seizure-free interval (6–12 months)
- Carry seizure action plan
- Medic-alert bracelet
- Buccal midazolam at home for cluster seizures
- Family training in rescue manoeuvres
Monitoring & Follow-up
- Seizure diary (apps like Epilepsy Journal)
- Serum levels only when non-adherence suspected or toxicity feared
- CBC and LFT at baseline and if symptomatic
- Bone density every 2–3 years on long-term enzyme-inducers
- Mental-health screening (depression risk 30–50%)
- Annual neurologist review
Infographic: Epilepsy Treatment Pathway
The Indian Context
- 12 million Indians live with epilepsy
- ~70% treatment gap (receiving no or inadequate care)
- Phenobarbitone and phenytoin still widely used due to cost
- HLA-B*1502 testing recommended before carbamazepine
- Social stigma, education and employment challenges persist
- Indian Epilepsy Society guidelines (2024) emphasise generic-brand continuity
- Neurocysticercosis a major cause — albendazole + steroid under cover of ASM
Latest 2024–2026 Evidence
- ESETT trial (2019 published, now standard): levetiracetam, fosphenytoin and valproate equally effective in benzodiazepine-refractory status.
- Cenobamate shows exceptional seizure-freedom rates in focal epilepsy.
- Fenfluramine effective in Lennox-Gastaut (2024 FDA extension).
- Ganaxolone approved for CDKL5 deficiency and super-refractory status.
- 2024 ILAE epilepsy classification update refines focal-aware vs focal-impaired-awareness terminology.
- Wearable seizure-detection devices (Empatica Embrace2) FDA-cleared for tonic-clonic seizures.
Myths vs Facts
| Myth | Fact |
|---|---|
| Put a spoon in the mouth during a seizure | Never — risk of tooth and jaw injury |
| Epilepsy is contagious | No — it is a brain disorder, not infectious |
| People with epilepsy cannot work | Most can, with the right treatment |
| Treatment is lifelong for all | 50% of children outgrow their epilepsy |
| Only drugs can treat epilepsy | Surgery, diet, and neuromodulation help many |
| Herbs are safer than ASMs | Unproven and often interact dangerously |
10 Frequently Asked Questions
Q1. Is epilepsy treatment lifelong?
Not always — many children and some adults can taper ASMs after 2–5 years seizure-free.
Q2. Can epilepsy be cured by surgery?
Up to 70–80% achieve seizure freedom in well-selected temporal-lobe cases.
Q3. Which is the safest ASM?
Levetiracetam and lamotrigine have favourable safety profiles for most adults.
Q4. What is the role of the ketogenic diet?
Highly effective in drug-resistant childhood epilepsies.
Q5. Is cannabidiol legal in India?
Prescription-only in specific indications; availability varies.
Q6. Can I drive on ASMs?
Only after a documented seizure-free interval per Indian/your-country driving regulations.
Q7. Do ASMs affect intelligence?
Modern ASMs have minimal cognitive impact at therapeutic doses; valproate in pregnancy is an exception.
Q8. What should I do during a seizure?
Protect the person from injury, roll onto the side, time the seizure, call help if > 5 min.
Q9. Can epilepsy treatment prevent SUDEP?
Yes — seizure freedom is the single biggest protective factor.
Q10. Should I switch between generic brands?
Avoid for narrow therapeutic index ASMs (phenytoin, carbamazepine, valproate); for levetiracetam and lamotrigine generally safe.
Summary
Modern epilepsy treatment starts with the right ASM matched to seizure type, uses monotherapy first, and escalates to surgery, neuromodulation, dietary therapy, or newer agents for the 30% who are drug-resistant. Prompt status epilepticus care saves lives. Pregnancy, pediatric, and elderly populations need tailored regimens. Supportive lifestyle, trigger avoidance, mental-health care, and SUDEP prevention are essential.
Conclusion
Living well with epilepsy is possible for the majority with modern epilepsy treatment. See a neurologist early. For patients and families in Nashik, I provide general health consultation at www.entspecialistinnashik.com and can refer to local epilepsy specialists.
📞 ENT & Health Consultation
Dr. Sagar Rajkuwar (MS-ENT)
Prabha ENT Clinic, Ambad, Nashik
📱 7387590194 | 9892596635
🌐 www.entspecialistinnashik.com
References
- WHO — Epilepsy
- CDC — Epilepsy
- NHS — Epilepsy
- NICE — Epilepsies in Children, Young People and Adults
- International League Against Epilepsy
- Epilepsy Foundation
- NIH — Epilepsy
Related Articles on Healthuseful
External Links
- YouTube: Healthuseful YouTube Channel
- Facebook: Positive Mind Healthcare Facebook
Medical Disclaimer: This article is for informational purposes only and does not substitute professional medical advice. Please consult a qualified healthcare provider for diagnosis and treatment.
Written by Dr. Sagar Rajkuwar, MS-ENT. Clinic: www.entspecialistinnashik.com | Nashik, Maharashtra, India | For appointments visit the clinic website.
